-
Sterling announces pilot plant facility expansion is operational
Jun 4, 2019, 09:10 AM by Michael CroftNEWCASTLE, UK - Jun 4, 2019 - Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million investment last yearFull story -
2 Chinese Babies With Edited Genes May Face Higher Risk Of Premature Death
Jun 3, 2019, 12:40 PM by Michael CroftFull storyNPR.org | There are new concerns about the world's first genetically modified babies. It appears that the genetic variation a Chinese scientist was trying to recreate when he edited twin girls' DNA may be more harmful than helpful to health overall, according to a study published Monday.
-
BioIVT HEPATOPAC® Meeting to Highlight Advances in Drug Discovery Research
Jun 3, 2019, 10:49 AM by Michael CroftWESTBURY, NY - Jun 3, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a HEPATOPAC Meeting at the AC Hotel by Marriott, San Francisco Airport/Oyster Point Waterfront on June 7Full story -
PerkinElmer Joins Accenture's Open Partner Ecosystem
Jun 3, 2019, 09:55 AM by Michael CroftFull storyBio-IT World | PerkinElmer has signed on to Accenture's open partner ecosystem and will integrate its big data technology and content into the cloud-based platform's wider efforts in drug discovery and research.
-
BOC Sciences to Reorganize Custom Synthesis for the Pharmaceutical Industry
Jun 2, 2019, 22:09 PM by Michael CroftSHIRLEY, LONG ISLAND CITY, NY, UNITED STATES - Jun 3, 2019 - The New York-based chemical vendor BOC Sciences announces to reorganize its custom synthesis for the pharmaceutical industryFull story -
Grail Outlines Its Plans For A Blood Test To Detect Cancer
May 31, 2019, 10:00 AM by Michael CroftFull storySTAT | Could a blood test detect cancer in healthy people? Grail, a Menlo Park, Calif.-based company, has raised $1.6 billion in venture capital to prove the answer is yes.
-
MR Solutions’ multi-modality, cryogen free technology is recognised as the norm at the ISMRM meeting in Montreal
May 30, 2019, 10:52 AM by Michael CroftGUILDFORD, UNITED KINGDOM - May 24, 2019 - MR Solutions high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM)[i], in Montreal last weekFull story -
CRF Bracket’s World-Class Clinical Research Technology wins European PIN Award for Second Year in Row
May 30, 2019, 10:33 AM by Michael CroftPHILADELPHIA, PA - May 30, 2019 - CRF Brackets Romania office celebrates yet another European award after being named IT Company of the Year in Romanias Regional IT & Outsourcing Industry Awards (also known as the PIN Awards)Full story -
ACD/Labs, Genomenon, Accenture, And More: News From May 2019
May 30, 2019, 09:25 AM by Michael CroftFull storyBio-IT World | May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including ACD/Labs, Genomenon, Accenture, and more.
-
Creative Biolabs Released Professional Carbohydrate Based Conjugation Services
May 30, 2019, 02:49 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 30, 2019 - Creative Biolabs, a global company pioneering new biotechnologies, released professional carbohydrate based conjugation services in order to regulate antigen interactionFull story -
MGI Sues Illumina for Patent Infringement in the United States
May 29, 2019, 16:55 PM by Michael CroftBio-IT World News Brief | Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware.Full story -
Microway Boosts Solutions with 2nd Generation Intel Xeon Scalable Processors
May 29, 2019, 11:47 AM by Michael CroftPLYMOUTH, MA, US - May 29, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces that bleeding-edge 2nd Generation Intel® Xeon® Scalable processors (Cascade Lake-SP) are now shipping in volume across all Microway Xeon offerings, including next-generation NumberSmasher clusters, servers, and WhisperStationsFull story -
BioIVT Named Service Provider for Promega Immunotherapy Bioassays
May 29, 2019, 09:46 AM by Michael CroftWESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology researchFull story -
BOC Sciences Continues to Broaden Its Inhibitor Range for Researchers
May 29, 2019, 01:39 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 29, 2019 - As one of the world's leading chemical suppliers, BOC Sciences announces to continuously broaden its small molecule inhibitor range in response to an increasingly urgent need to find a cure for some major diseases that are inflicting the human beingsFull story -
Creative Proteomics Has Announced a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services
May 28, 2019, 23:22 PM by Michael CroftSHIRLEY, NY - May 29, 2019 - SHIRLEY, NY – May 29, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchersFull story -
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference
May 28, 2019, 09:06 AM by Michael CroftPITTSBURGH, PA, UNITED STATES - May 24, 2019 - Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the companys lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, FloridaFull story -
Certara Introduces Integral, its Next-generation Data Repository
May 28, 2019, 08:11 AM by Michael CroftPRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical dataFull story -
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data
May 28, 2019, 05:12 AM by Michael CroftMILFORD, MA, US - May 25, 2019 -Full story- TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system
- Significant increase in diuresis, net negative fluid balance, improvement of kidney function and improvement in clinical symptoms
- Significant drop in CVP while systolic BP remained stable
-
Creative Diagnostics Launches IHC/Pathology Antibodies for Research
May 28, 2019, 02:42 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 28, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced it has launched a series of IHC/Pathology antibodies for research useFull story -
CanDIG to be part of new Canadian Digital Health and Discovery Platform
May 27, 2019, 14:03 PM by Michael CroftMONTRÉAL, QC, CANADA - May 27, 2019 - Today, Minister Navdeep Bains announced funding for the Digital Health and Discovery Platform (DHDP) through the health and biosciences stream of the Strategic Innovation FundFull story